Trademark: 79324818
Word
YOUR FOUNTAIN OF YOUTH
Status Date
Tuesday, June 20, 2023
Registration Number
7082461
Registration Date
Tuesday, June 20, 2023
Filing Date
Tuesday, May 25, 2021
Published for Opposition
Tuesday, April 4, 2023
5 Stem cell preparations used for the treatment of peripheral neuropathy, peripheral vascular disease, critical limb ischemia, wound care, end-stage heart diseases, angina pectoris, ischemic and dilated cardiomyopathy, COPD, idiopathic pulmonary hypertension and other diseases of ischemia; biomedical autologous preparations in the nature of hematopoietic stem cells that include a synergetic cell population of angiogenic cell precursors used for the treatment of minor health disorders to prevent them from becoming severe health disorders, and to treat severe health disorders on an ongoing basis to slow, eliminate, or reverse their progress
1 Stem cell preparations used for research of peripheral neuropathy, peripheral vascular disease, critical limb ischemia, wound care, end-stage heart diseases, angina pectoris, ischemic and dilated cardiomyopathy, COPD, idiopathic pulmonary hypertension and other diseases of ischemia; biomedical autologous preparations in the nature of hematopoietic stem cells that include a synergetic cell population of angiogenic cell precursors used for research, other experiments of minor health disorders to prevent them from becoming severe health disorders
44 Services in the medical field, namely, medical services performed in a laboratory for medical research companies, the foregoing consisting of extracting, processing, culturing, testing, injecting or administering under medical supervision the products derived from blood and blood components being a novel human cell population; services in the medical field, namely, medical services performed in a laboratory for medical research companies, the foregoing consisting of selecting, processing, manipulating, purging and storing stem cells from blood and adding regenerative cells to the body
42 Research and development in the field of blood, blood products being comprised of a synergistic cell population of stem cells including angiogenic cell precursors, and blood testing; scientific research services in the field of blood and stem cells
Oct 10, 2023
Final Decision Transaction Processed By Ib
Sep 21, 2023
Final Disposition Notice Sent To Ib
Sep 21, 2023
Final Disposition Processed
Sep 20, 2023
Final Disposition Notice Created, To Be Sent To Ib
Jun 20, 2023
Notice Of Registration Confirmation Emailed
Jun 20, 2023
Registered-Principal Register
Apr 5, 2023
Notification Processed By Ib
Apr 4, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 4, 2023
Published For Opposition
Mar 15, 2023
Notification Of Possible Opposition Sent To Ib
Mar 15, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 15, 2023
Notification Of Notice Of Publication E-Mailed
Feb 27, 2023
Approved For Pub - Principal Register
Feb 27, 2023
Examiner's Amendment Entered
Feb 27, 2023
Notification Of Examiners Amendment E-Mailed
Feb 27, 2023
Examiners Amendment E-Mailed
Feb 27, 2023
Examiners Amendment -Written
Feb 7, 2023
Refusal Processed By Ib
Jan 31, 2023
Notification Of Final Refusal Emailed
Jan 31, 2023
Final Refusal E-Mailed
Jan 31, 2023
Final Refusal Written
Jan 10, 2023
Teas/Email Correspondence Entered
Jan 9, 2023
Correspondence Received In Law Office
Jan 9, 2023
Teas Response To Office Action Received
Dec 27, 2022
Notification Of Non-Final Action E-Mailed
Dec 27, 2022
Non-Final Action E-Mailed
Dec 27, 2022
Non-Final Action Written
Dec 13, 2022
Teas/Email Correspondence Entered
Dec 13, 2022
Correspondence Received In Law Office
Dec 13, 2022
Teas Response To Office Action Received
Oct 20, 2022
Assigned To Examiner
Jul 5, 2022
Refusal Processed By Ib
Jun 15, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jun 15, 2022
Refusal Processed By Mpu
May 17, 2022
Non-Final Action (Ib Refusal) Prepared For Review
May 16, 2022
Non-Final Action Written
May 10, 2022
Correction From The Ib Examined, No Action Is Needed
May 2, 2022
Correction Transaction Received From Ib
Feb 7, 2022
Assigned To Examiner
Nov 12, 2021
Application Filing Receipt Mailed
Nov 8, 2021
New Application Office Supplied Data Entered
Nov 4, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
